Premier Biomedical Stock Forecast

Sell candidate since Jun 22, 2026 Loss -4.76%

The Premier Biomedical Inc stock price fell by -4.76% on the last day (Tuesday, 23rd Jun 2026) from $0.0012 to $0.0011. During the last trading day the stock fluctuated 27.27% from a day low at $0.0011 to a day high of $0.0014. The price has fallen in 6 of the last 10 days and is down by -8.33% for this period. Volume has increased on the last day by 24 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 39 million shares were bought and sold for approximately $43.41 thousand.

Given the current short-term trend, the stock is expected to rise 106.20% during the next 3 months and, with a 90% probability hold a price between $0.0023 and $0.0044 at the end of this 3-month period.

BIEI Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Premier Biomedical Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0011 and $0.0013. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 15, 2026, and so far it has fallen -35.29%. Further fall is indicated until a new bottom pivot has been found. Premier Biomedical Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Premier Biomedical Inc stock

Premier Biomedical Inc finds support from accumulated volume at $0.0011 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0003 between high and low, or 27.27%. For the last week, the stock has had daily average volatility of 22.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIEI) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Premier Biomedical Inc to open at $0.0012, and during the day (based on 14 day Average True Range), to move between $0.0010 and $0.0012, which gives a possible trading interval of +/-$0.0003 (+/-28.56%) up or down from last closing price. If Premier Biomedical Inc takes out the full calculated possible swing range there will be an estimated 28.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0011 (4.55%) than the resistance at $0.0012 (5.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Premier Biomedical Inc stock A Buy?

The Premier Biomedical Inc stock holds several negative signals and despite the positive trend, we believe Premier Biomedical Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.794 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.0012 ( 9.09%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk